Athira Scientific Publications and Presentations
PRESENTATIONS
CTAD 2024
SfN 2024
AAIC 2024
ENCALS 2024
ALS DDS 2024
AAN 2024
ASENT 2024
AD/PD 2024
ALS/MND 2023
SfN 2023
CTAD 2023
NEALS 2023
AAIC 2023
ALS DDS 2023
AAN 2023
AD/PDTM 2023
ASENT 2023
MNDA 2022
CTAD 2022
SfN 2022
AAIC 2022
PNS 2022
AD/PDTM 2022
AAIC 2021
ASENT 2022
CTAD 2021
CTAD 2019
PUBLICATIONS
Neurotherapeutics (Reda et al.)
Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer’s disease
April 11, 2024
Frontiers in Neuroscience (Berthiaume, Reda at al.)
ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS
February 8, 2024
Journal of Alzheimer’s Disease (Moebius and Church)
The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators
March 7, 2023
Neurotherapeutics (Johnston et al.)
Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia
December 20, 2022
Neural Plasticity (Olichney et al.)
Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential
November 8, 2022
Journal of Alzheimer’s Disease (Hua et al.)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer’s Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial
April 5, 2022